FTO and obesity due to melanocortin 4 receptor deficiency: Meta-analysis studies (65–67) have validated and confirmed that the influence of FTO variants on obesity risk is attenuated through physical activities as well as dietary and drug-based interventions (68, 69), although the underlying mechanism remains elusive.